242 related articles for article (PubMed ID: 24401087)
1. Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.
Wei M; He Q; Yang Z; Wang Z; Zhang Q; Liu B; Gu Q; Su L; Yu Y; Zhu Z; Zhang G
BMC Cancer; 2014 Jan; 14():10. PubMed ID: 24401087
[TBL] [Abstract][Full Text] [Related]
2. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
[TBL] [Abstract][Full Text] [Related]
3. Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1).
Wei M; Liu B; Gu Q; Su L; Yu Y; Zhu Z
Cell Oncol (Dordr); 2013 Feb; 36(1):79-93. PubMed ID: 23184467
[TBL] [Abstract][Full Text] [Related]
4. TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1.
Gizard F; Robillard R; Barbier O; Quatannens B; Faucompré A; Révillion F; Peyrat JP; Staels B; Hum DW
Mol Cell Biol; 2005 Jun; 25(11):4335-48. PubMed ID: 15899840
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.
Diep CH; Charles NJ; Gilks CB; Kalloger SE; Argenta PA; Lange CA
Cell Cycle; 2013 May; 12(9):1433-49. PubMed ID: 23574718
[TBL] [Abstract][Full Text] [Related]
6. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).
Groshong SD; Owen GI; Grimison B; Schauer IE; Todd MC; Langan TA; Sclafani RA; Lange CA; Horwitz KB
Mol Endocrinol; 1997 Oct; 11(11):1593-607. PubMed ID: 9328342
[TBL] [Abstract][Full Text] [Related]
7. Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kip1 gene.
Gizard F; Robillard R; Gervois P; Faucompré A; Révillion F; Peyrat JP; Hum WD; Staels B
FEBS Lett; 2005 Oct; 579(25):5535-41. PubMed ID: 16216245
[TBL] [Abstract][Full Text] [Related]
8. ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-p27 axis.
Wang L; Shen S; Xiao H; Ding F; Wang M; Li G; Hu F
Carcinogenesis; 2020 Jul; 41(5):711-721. PubMed ID: 31430374
[TBL] [Abstract][Full Text] [Related]
9. Progesterone stimulates proliferation and promotes cytoplasmic localization of the cell cycle inhibitor p27 in steroid receptor positive breast cancers.
Kariagina A; Xie J; Langohr IM; Opreanu RC; Basson MD; Haslam SZ
Horm Cancer; 2013 Dec; 4(6):381-90. PubMed ID: 23996077
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.
Knutson TP; Daniel AR; Fan D; Silverstein KA; Covington KR; Fuqua SA; Lange CA
Breast Cancer Res; 2012 Jun; 14(3):R95. PubMed ID: 22697792
[TBL] [Abstract][Full Text] [Related]
11. The antiprogestin Lonaprisan inhibits breast cancer cell proliferation by inducing p21 expression.
Busia L; Faus H; Hoffmann J; Haendler B
Mol Cell Endocrinol; 2011 Feb; 333(1):37-46. PubMed ID: 21138753
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.
Dressing GE; Knutson TP; Schiewer MJ; Daniel AR; Hagan CR; Diep CH; Knudsen KE; Lange CA
Mol Endocrinol; 2014 Apr; 28(4):442-57. PubMed ID: 24606123
[TBL] [Abstract][Full Text] [Related]
13. Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.
Diep CH; Knutson TP; Lange CA
Mol Cancer Res; 2016 Feb; 14(2):141-62. PubMed ID: 26577046
[TBL] [Abstract][Full Text] [Related]
14. Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer.
Proietti CJ; Béguelin W; Flaqué MC; Cayrol F; Rivas MA; Tkach M; Charreau EH; Schillaci R; Elizalde PV
Steroids; 2011 Mar; 76(4):381-92. PubMed ID: 21184768
[TBL] [Abstract][Full Text] [Related]
15. Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth.
Proietti CJ; Izzo F; Díaz Flaqué MC; Cordo Russo R; Venturutti L; Mercogliano MF; De Martino M; Pineda V; Muñoz S; Guzmán P; Roa JC; Schillaci R; Elizalde PV
Mol Endocrinol; 2015 Oct; 29(10):1468-85. PubMed ID: 26340407
[TBL] [Abstract][Full Text] [Related]
16. Progesterone up-regulates p27 through an increased binding of the progesterone receptor-A-p53 protein complex onto the non-canonical p53 binding motif in HUVEC.
Hsu SP; Lin PH; Chou CM; Lee WS
J Steroid Biochem Mol Biol; 2019 Jan; 185():163-171. PubMed ID: 30145226
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
[TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1).
Chen CC; Hardy DB; Mendelson CR
J Biol Chem; 2011 Dec; 286(50):43091-102. PubMed ID: 22020934
[TBL] [Abstract][Full Text] [Related]
19. Ligand activated progesterone receptor B drives autophagy-senescence transition through a Beclin-1/Bcl-2 dependent mechanism in human breast cancer cells.
De Amicis F; Guido C; Santoro M; Giordano F; Donà A; Rizza P; Pellegrino M; Perrotta I; Bonofiglio D; Sisci D; Panno ML; Tramontano D; Aquila S; Andò S
Oncotarget; 2016 Sep; 7(36):57955-57969. PubMed ID: 27462784
[TBL] [Abstract][Full Text] [Related]
20. Progesterone receptor activation is required for folic acid-induced anti-proliferation in colorectal cancer cell lines.
Kuo CT; Lee WS
Cancer Lett; 2016 Aug; 378(2):104-10. PubMed ID: 27233474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]